Yoshiaki Soejima

Dr. Yoshiaki Soejima

Okayama University, Okayama, Japan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KYKoichiro Yamamoto
Koichiro Yamamoto
YNYasuhiro Nakano
Yasuhiro Nakano
NINahoko Iwata
Nahoko Iwata
YSYoshiaki Soejima
Yoshiaki Soejima
ASAtsuhito Suyama
Atsuhito Suyama
FOFumio Otsuka
Fumio Otsuka

13 April 2022 in Medicina
Verified
Journal Article
Open access
PDF file
YSYoshiaki Soejima
Yoshiaki Soejima
Yuki OtsukaYuki Otsuka
Yuki Otsuka
KTKazuki Tokumasu
Kazuki Tokumasu
YNYasuhiro Nakano
Yasuhiro Nakano
KHKo Harada
Ko Harada
FOFumio Otsuka
Fumio Otsuka
After the acute phase of COVID-19, some patients have been reported to have persistent symptoms including general fatigue. We have established a COVID-19 aftercare clinic (CAC) to provide care for an increasing number of these patients. Here, we report the case of a 36-year-old man who developed post-COVID fatigue after acute infection with SARS-CoV-2. In the acute phase of COVID-19, the patient’s fever resolved within four days; however, general fatigue persisted for three months, and he visited our CAC 99 days after the initial infection. Examination revealed a high Aging Male’s Symptoms (AMS) score of 44 and low free testosterone (FT) level of 5.5 pg/mL, which meet the Japanese criteria of late-onset hypogonadism (LOH) syndrome. Imaging studies revealed an atrophic pituitary in addition to fatty liver and low bone mineral density. Anterior pituitary function tests showed a low follicle-stimulating hormonelevel and delayed reaction of luteinizing hormone (LH) after gonadotropin-releasing hormone (GnRH) stimulation, indicating the possibility of hypothalamic hypogonadism in addition to primary hypogonadism seen in patients with post-COVID-19 conditions. After the initiation of Japanese traditional medicine (Kampo medicine: hochuekkito followed by juzentaihoto), the patient’s symptoms as well as his AMS score and serum FT level were noticeably improved. Furthermore, follow-up tests of GnRH stimulation revealed improvements in LH responsiveness. Although many patients have been reported to meet the criteria of ME/CFS such as our case, we emphasize the possibility of other underlying pathologies including LOH syndrome. In conclusion, LOH syndrome should be considered a cause of general fatigue in patients with post-COVID-19 conditions and herbal treatment might be effective for long COVID symptoms due to LOH (264 words).

18 May 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KYKoichiro Yamamoto
Koichiro Yamamoto
YNYasuhiro Nakano
Yasuhiro Nakano
NINahoko Iwata
Nahoko Iwata
YSYoshiaki Soejima
Yoshiaki Soejima
ASAtsuhito Suyama
Atsuhito Suyama
FOFumio Otsuka
Fumio Otsuka

1 October 2020 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
YNYasuhiro Nakano
Yasuhiro Nakano
THToru Hasegawa
Toru Hasegawa
CKChiaki Kashino
Chiaki Kashino
NINahoko Iwata
Nahoko Iwata
KYKoichiro Yamamoto
Koichiro Yamamoto
FOFumio Otsuka
Fumio Otsuka

Verified
Journal Article
Open access
PDF file
YSYoshiaki Soejima
Yoshiaki Soejima
INIwata Nahoko
Iwata Nahoko
YNYasuhiro Nakano
Yasuhiro Nakano
KYKoichiro Yamamoto
Koichiro Yamamoto
ASAtsuhito Suyama
Atsuhito Suyama
FOFumio Otsuka
Fumio Otsuka
Roles of Clock genes and the bone morphogenetic protein (BMP) system in the regulation of gonadotropin secretion by gonadotropin-releasing hormone (GnRH) were investigated using mouse gonadotropin LβT2 cells. It was found that luteinizing hormone (LH)β mRNA expression level in LβT2 cells changed gradually over time, with LHβ expression being suppressed in the early phase up to 12 h and then elevated in the late phase 24 h after GnRH stimulation. In addition, the mRNA expression levels of Clock genes, including Bmal1, Clock, Per2, and Cry1, also showed temporal changes mimicking the pattern of LHβ expression in the presence and absence of GnRH. Notably, the expression levels of Bmal1 and Clock showed strong positive correlations with LHβ mRNA expression levels. Moreover, a functional link of the ERK signaling of mitogen-activated protein kinases (MAPKs) in the suppression of LHβ mRNA expression, as well as Bmal1 and Clock mRNA expression by GnRH at the early phase, was revealed. Inhibition of Bmal1 and Clock expression using siRNA was involved in the reduction in LHβ mRNA levels in the late phase 24 h after GnRH stimulation. Furthermore, in the presence of BMP-6 and -7, late-phase Bmal1 and LHβ mRNA expression after GnRH stimulation was significantly attenuated. Collectively, the results indicated that LH expression in gonadotrope cells exhibits Bmal1/Clock-dependent fluctuations under the influence of GnRH and that the fluctuations are regulated by ERK and BMPs in the early and late stages, respectively, in a phase-dependent manner after GnRH stimulation.

30 August 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
OMOsamu Mese
Osamu Mese
Yuki OtsukaYuki Otsuka
Yuki Otsuka
YSYasue Sakurada
Yasue Sakurada
KTKazuki Tokumasu
Kazuki Tokumasu
YSYoshiaki Soejima
Yoshiaki Soejima
FOFumio Otsuka
Fumio Otsuka
To characterize changes in markers of oxidative stress for the clinical evaluation of patients with long COVID, we assessed oxidative stress and antioxidant activity based on serum samples from patients who visited our clinic between May and November 2024. Seventy-seven patients with long COVID (41 [53%] females and 36 [47%] males; median age, 44 years) were included. Median [interquartile range] serum levels of diacron-reactive oxygen metabolites (d-ROM; CARR Unit), biological antioxidant potential (BAP; μmol/L), and oxidative stress index (OSI) were 533.8 [454.9–627.6], 2385.8 [2169.2–2558.1] and 2.0 [1.7–2.5], respectively. Levels of d-ROMs (579.8 vs. 462.2) and OSI (2.3 vs. 1.8), but not BAP (2403.4 vs. 2352.6), were significantly higher in females than in males. OSI levels positively correlated with age and body mass index, whereas BAP levels negatively correlated with these parameters. d-ROM and OSI levels were significantly associated with inflammatory markers, including C-reactive protein (CRP) and fibrinogen, whereas BAP levels were inversely correlated with CRP and ferritin levels. Notably, serum free thyroxine levels were negatively correlated with d-ROMs and OSI, whereas cortisol levels were positively correlated with d-ROMs. Among long COVID symptoms, patients reporting brain fog exhibited significantly higher OSI levels (2.2 vs. 1.8), particularly among females (d-ROMs: 625.6 vs. 513.0; OSI: 2.4 vs. 2.0). The optimal OSI cut-off values were determined to be 1.32 for distinguishing long COVID from healthy controls and 1.92 for identifying brain fog among patients with long COVID. These findings suggest that oxidative stress markers may serve as indicators for the presence or prediction of psycho-neurological symptoms associated with long COVID in a gender-dependent manner.